Conditioning regimen for hematopoietic cell transplant in transfusion dependent thalassemia: Recommendations from the EBMT practice harmonisation and guidelines committee

This publication has 77 references indexed in Scilit:

• Impairment of Innate Immunity and Depletion of Vaccine‐Induced Memory B and T Cells in the Absence of the Spleen
  American Journal of Hematology, 2025
• A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
  Clinical Drug Investigation, 2022
• Liver biopsy for assessment of chronic liver diseases: a synopsis
  Clinical and Experimental Medicine, 2022
• Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major
  Annals of Hematology, 2022
• Pretransplant myeloid and immune suppression, reduced toxicity conditioning with posttransplant cyclophosphamide: Initial outcomes of novel approach for matched unrelated donor hematopoietic stem cell transplant for hemoglobinopathies
  Pediatric Blood & Cancer, 2021
• Impact of splenectomy on outcomes of hematopoietic stem cell transplantation in pediatric patients with transfusion‐dependent thalassemia
  Pediatric Blood & Cancer, 2020
• Pharmacokinetics and Pharmacodynamics of Treosulfan in Patients With Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
  Clinical Pharmacology & Therapeutics, 2018
• Transplantation in thalassemia: Revisiting the Pesaro risk factors 25 years later
  American Journal of Hematology, 2017
• Long‐term results of survival in patients with thalassemia major treated with bone marrow transplantation
  American Journal of Hematology, 2008
• Reduced intensity stem cell transplantation for treatment of class 3 Lucarelli severe thalassemia patients
  American Journal of Hematology, 2007